Viewing Study NCT02974803


Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2026-03-05 @ 11:30 PM
Study NCT ID: NCT02974803
Status: TERMINATED
Last Update Posted: 2021-08-20
First Post: 2016-11-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases
Sponsor: Canadian Cancer Trials Group
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-02-09
Start Date Type: ACTUAL
Primary Completion Date: 2020-07-29
Primary Completion Date Type: ACTUAL
Completion Date: 2020-07-29
Completion Date Type: ACTUAL
First Submit Date: 2016-11-23
First Submit QC Date: None
Study First Post Date: 2016-11-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-05-05
Results First Submit QC Date: None
Results First Post Date: 2021-08-17
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-08-18
Last Update Post Date: 2021-08-20
Last Update Post Date Type: ACTUAL